Physiological antioxidative network of the bilirubin system in aging and age-related diseases

Frontiers in Pharmacology

Volumn 3 MAR, Issue , 2012, Pages

  Kim, Sung Young ^a   Park, Sang Chul ^a  

^a Gachon University   (South Korea)

Author keywords

Aging; Antioxidant; Bilirubin; Biliverdin reductase; Cellular senescence; Heme oxygenase; Lipid peroxidation; Reactive oxygen species

Indexed keywords

ALLOPURINOL; AMYLOID BETA PROTEIN; ATORVASTATIN; BILIRUBIN; BILIVERDIN; BILIVERDIN REDUCTASE; HEME OXYGENASE; HEME OXYGENASE 2; OXIDOREDUCTASE; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

AGING; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CATALYSIS; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE;

EID: 84865967056     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00045     Document Type: Article

References (132)

1. Adibhatla, R.M., and Hatcher, J.F. (2007). Role of lipids in brain injury and diseases. Future Lipidol. 2, 403-422.
2. Adibhatla, R.M., and Hatcher, J.F. (2008). Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 41, 560-567.
3. Adibhatla, R.M., and Hatcher, J.F. (2010). Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 12, 125-169.
4. Adibhatla, R.M., Hatcher, J.F., and Dempsey, R.J. (2006). Lipids and lipidomics in brain injury and diseases. AAPS J. 8, E314-E321.
5. Ahotupa, M., and Asankari, T.J. (1999). Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. Free Radic. Biol. Med. 27, 1141-1150.
6. Alcorta, D.A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., and Barrett, J. C. (1996). Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 93, 13742-13747.
7. Alexandra Brito, M., Silva, R.F., and Brites, D. (2006). Bilirubin toxicity to human erythrocytes: a review. Clin. Chim. Acta 374, 46-56.
8. Baranano, D.E., Rao, M., Ferris, C.D., and Snyder, S.H. (2002). Biliverdin reductase: a major physiologic cytoprotectant. Proc. Natl. Acad. Sci. U.S.A. 99, 16093-16098.
9. Barja, G. (2002). Endogenous oxidative stress: relationship to aging, longevity and caloric restriction. Ageing Res. Rev. 1, 397-411.
10. Barone, E., Di Domenico, F., Cenini, G., Sultana, R., Coccia, R., Preziosi, P., Perluigi, M., Mancuso, C., and Butterfield, D.A. (2011a). Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. J. Alzheimers Dis. 25, 623-633
11. Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Paul Murphy, M., Head, E., and Allan Butterfield, D. (2011b). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. J. Neurochem. 120, 135-146.
12. Basu, A.K., and Marnett, L.J. (1984). Molecular requirements for the mutagenicity of malondialdehyde and related acroleins. Cancer Res. 44, 2848-2854.
13. Bejma,J.,Ramires,P., and Ji,L. L. (2000). Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol. Scand. 169, 343-351.
14. Bliuger, A.F., Dudnik, L.B., Maiore, A., and Mieze, I.E. (1985). Role of bilirubin as a natural antioxidant in regulating lipid peroxidation intensity in acute viral hepatitis. Biull. Eksp. Biol. Med. 99, 166-168.
15. Bourre, J.M. (1988). Free radicals, polyunsaturated fatty acids, cell death, brain aging. C.R. Seances Soc. Biol. Fil. 182, 5-36.
16. Brash, A.R. (1999). Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274, 23679-23682.
17. Butler, R., Morris, A.D., Belch, J.J., Hill, A., and Struthers, A.D. (2000). Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35, 746-751.
18. Butterfield, D.A., and Lauderback, C.M. (2002). Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050-1060.
19. Butterfield, D.A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., and Sultana, R. (2006). Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 397, 170-173.
20. Campisi, J., and d'Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
21. Catalá, A. (2009). Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157, 1-11.
22. Chang, E.F., Wong, R.J., Vreman, H.J., Igarashi, T., Galo, E., Sharp, F.R., Stevenson, D.K., and Noble-Haeusslein, L.J. (2003). Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J. Neurosci. 23, 3689-3696.
23. Chen, J., Tu, Y., Moon, C., Nagata, E., and Ronnett, G.V. (2003). Heme oxygenase-1 and heme oxygenase-2 have distinct roles in the proliferation and survival of olfactory receptor neurons mediated by cGMP and bilirubin, respectively. J. Neurochem. 85, 1247-1261.
24. Chen, Q., and Ames, B.N. (1994). Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. U.S.A. 91, 4130-4134.
25. Chen, Q., Fischer, A., Reagan, J.D., Yan, L.J., and Ames, B.N. (1995). Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. U.S.A. 92, 4337-4341.
26. Chen,Q.M., Bartholomew,J.C., Campisi, J., Acosta, M., Reagan, J.D., and Ames,B.N. (1998). Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332(Pt 1), 43-50.
27. Cheriyath, P., Gorrepati, V.S., Peters, I., Nookala, V., Murphy, M.E., Srouji, N., and Fischman, D. (2010). High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999-2006. J. Clin. Med. Res. 2, 201-206.
28. Dekker, D., Dorresteijn, M.J., Pijnenburg, M., Heemskerk, S., Rasing-Hoogveld, A., Burger, D.M., Wagener, F.A., and Smits, P. (2011). The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 31, 458-463.
29. Dhalla, N.S., Temsah, R.M., and Netticadan, T. (2000). Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655-673.
30. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., and et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92, 9363-9367.
31. Ding, B., Gibbs, P.E., Brookes, P.S., and Maines, M.D. (2011). The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters beta-adrenergic receptor ligand-mediated cardiac dysfunction. FASEB J. 25, 301-313.
32. Djousse, L., Levy, D., Cupples, L.A., Evans, J.C., D'Agostino, R.B., and Ellison, R.C. (2001). Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am. J. Cardiol. 87, 1196-1200
33. Djousse, L., Rothman, K.J., Cupples, L.A., Levy, D., and Ellison, R.C. (2003). Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study). Am. J. Cardiol. 91, 485-488.0
34. Dore, S., Goto, S., Sampei, K., Blackshaw, S., Hester, L.D., Ingi, T., Sawa, A., Traystman, R.J., Koehler, R.C., and Snyder, S.H. (2000). Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia. Neuroscience 99, 587-592.
35. Dore, S., Sampei, K., Goto, S., Alkayed, N.J., Guastella, D., Blackshaw, S., Gallagher, M., Traystman, R.J., Hurn, P.D., Koehler, R.C., and Snyder, S.H. (1999a). Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol. Med. 5, 656-663.
36. Dore, S., and Snyder, S.H. (1999). Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann. N. Y. Acad. Sci. 890, 167-172.
37. Dore, S., Takahashi, M., Ferris, C.D., Zakhary, R., Hester, L.D., Guastella, D., and Snyder, S.H. (1999b). Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. U.S.A. 96, 2445-2450.
38. Driver, A.S., Kodavanti, P.R., and Mundy, W.R. (2000). Agerelated changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol. Teratol. 22, 175-181.
39. Dudnik, L.B., Tsyupko, A.N., Khrenov, A.V., and Alessenko, A.V. (2001). Effect of bilirubin on lipid peroxidation, sphingomyelinase activity, and apoptosis induced by sphingosine and UV irradiation. Biochemistry Mosc. 66, 1019-1027.
40. Elias, M.M., Comin, E.J., Grosman, M.E., Galeazzi, S.A., and Rodriguez Garay, E.A. (1987). Possible mechanism of unconjugated bilirubin toxicity on renal tissue. Comp. Biochem. Physiol. A Comp. Physiol. 87, 1003-1007.
41. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. (2003). Are oxidative stressactivated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52, 1-8.
42. Fischman, D., Valluri, A., Gorrepati, V.S., Murphy, M.E., Peters, I., and Cheriyath, P. (2010). Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003-2006 data. J. Clin. Med. Res. 2, 256-260.
43. Fukui, M., Tanaka, M., Shiraishi, E., Harusato, I., Hosoda, H., Asano, M., Hasegawa, G., and Nakamura, N. (2008). Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 74, 1197-1201.
44. Fukui, M., Tanaka, M., Yamazaki, M., Hasegawa, G., Nishimura, M., Iwamoto, N., Ono, T., Imai, S., and Nakamura, N. (2011). Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetes. Diabet. Med. 28, 96-99.
45. Gil, L., Siems, W., Mazurek, B., Gross, J., Schroeder, P., Voss, P., and Grune, T. (2006). Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic. Res. 40, 495-505.
46. Gomi, F., Utsumi, H., Hamada, A., and Matsuo, M. (1993). Aging retards spin clearance from mouse brain and food restriction prevents its agedependent retardation. Life Sci. 52, 2027-2033.
47. Gonzalez-Fraguela, M. E., Cespedes, E. M., Arencibia, R., Broche, F., Gomez, A. A., Castellano, O., and Garcia, J. C. (1998). Indicators of oxidative stress and the effect of antioxidant treatment in patients with primary Parkinson disease. Rev. Neurol. 26, 28-33.
48. Hagen, T. M.,Yowe, D. L., Bartholomew, J. C.,Wehr,C. M.,Do,K. L.,Park,J.Y., and Ames, B. N. (1997). Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc. Natl. Acad. Sci. U.S.A. 94, 3064-3069.
49. Han, S. S., Na, K. Y., Chae, D. W., Kim,Y. S., Kim, S., and Chin, H. J. (2010). High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J. Exp. Med. 221, 133-140.
50. Hayflick, L. (1965). The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
51. Horsfall, L. J., Rait, G., Walters, K., Swallow, D. M., Pereira, S. P., Nazareth, I., and Petersen, I. (2011). Serum bilirubin and risk of respiratory disease and death. JAMA 305, 691-697.
52. Ilzecka, J., and Stelmasiak, Z. (2003). Serum bilirubin concentration in patients with amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. 105, 237-240.
53. Iwasaki, Y., Igarashi, O., Iwasa, Y., Hirano, K., Satoh, R., Iwamoto, K., Kawase, Y., Aoyagi, J., Ichikawa, Y., Kawabe, K., and Ikeda, K. (2005). Bilirubin and amyotrophic lateral sclerosis. Clin. Neurol. Neurosurg. 107, 160.
54. Kadl, A., Bochkov, V. N., Huber, J., and Leitinger, N. (2004). Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid. Redox Signal. 6, 311-320.
55. Kaneko, M., Elimban, V., and Dhalla, N. S. (1989). Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am. J. Physiol. 257, H804-H811.
56. Kaneto, H., Kajimoto, Y., Fujitani, Y., Matsuoka, T., Sakamoto, K., Matsuhisa, M., Yamasaki, Y., and Hori, M. (1999). Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in betacell dysfunction. Diabetologia 42, 1093-1097.
57. Kapitulnik,J.,and Maines,M. D. (2009). Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol. Sci. 30, 129-137.
58. Kim, S. Y., Kang, H. T., Choi, H. R., and Park, S. C. (2010a). Reduction of Nup107 attenuates the growth factor signaling in the senescent cells. Biochem. Biophys. Res. Commun. 401, 131-136.
59. Kim, S. Y., Ryu, S. J., Ahn, H. J., Choi, H. R., Kang, H. T., and Park, S. C. (2010b). Senescencerelated functional nuclear barrier by down-regulation of nucleocytoplasmic trafficking gene expression. Biochem. Biophys. Res. Commun. 391, 28-32.
60. Kim, S. Y., Kang, H. T., Choi, H. R., and Park, S. C. (2011a). Biliverdin reductase A in the prevention of cellular senescence against oxidative stress. Exp. Mol. Med. 43, 15-23.
61. Kim, S. Y., Ryu, S. J., Kang, H. T., Choi, H. R.,and Park,S. C. (2011b). Defective nuclear translocation of stressactivated signaling in senescent diploid human fibroblasts: a possible explanation for aging-associated apoptosis resistance. Apoptosis 16, 795-807.
62. Klein, J. A., and Ackerman, S. L. (2003). Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. 111, 785-793.
63. Ko, W. F., Helzlsouer, K. J., and Comstock, G. W. (1994). Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J. Natl. Cancer Inst. 86, 1874-1875.
64. Kravets, A., Hu, Z., Miralem, T., Torno, M. D., and Maines, M. D. (2004). Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. J. Biol. Chem. 279, 19916-19923.
65. Kuhn, H., Belkner, J., Wiesner, R., Schewe, T., Lankin, V. Z., and Tikhaze,A. K. (1992). Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids 5, 17-22.
66. Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T.,Yu, Z. X., Ferrans,V. J., Howard, B. H., and Finkel, T. (1999). Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274, 7936-7940.
67. Lerner-Marmarosh, N., Miralem, T., Gibbs, P. E., and Maines, M. D. (2008). Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc. Natl. Acad. Sci. U.S.A. 105, 6870-6875.
68. Lerner-Marmarosh, N., Shen, J., Torno, M. D., Kravets, A., Hu, Z., and Maines, M. D. (2005). Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc. Natl. Acad. Sci. U.S.A. 102, 7109-7114.
69. Lotharius, J., and Brundin, P. (2002). Pathogenesis of Parkinson's disease: dopamine, vesicles and alphasynuclein. Nat. Rev. Neurosci. 3, 932-942.
70. Maines, M. D. (1990). Multiple forms of biliverdin reductase: age-related change in pattern of expression in rat liver and brain. Mol. Pharmacol. 38, 481-485.
71. Maines, M. D. (2005). New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 20, 382-389.
72. Maines, M. D. (2010). Potential application of biliverdin reductase and its fragments to modulate insulin/IGF1/MAPK/PI3-K signaling pathways in therapeutic settings. Curr. Drug Targets 11, 1586-1594.
73. Maines, M. D., Ewing, J. F., Huang, T. J., and Panahian, N. (2001). Nuclear localization of biliverdin reductase in the rat kidney: response to nephrotoxins that induce heme oxygenase-1. J. Pharmacol. Exp. Ther. 296, 1091-1097.
74. Maines, M. D., Mark, J. A., and Ewing, J. F. (1993). Heme oxygenase, a likely regulator of cGMP production in the brain: induction in vivo of HO-1 compensates for depression in NO Synthase Activity. Mol. Cell. Neurosci. 4, 396-405.
75. Maines, M. D., Mayer, R. D., Erturk, E., Huang, T. J., and Disantagnese, A. (1999). The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma-pH and cofactor-specific increase in activity. J. Urol. 162, 1467-1472.
76. Mancuso, C. (2004). Heme oxygenase and its products in the nervous system. Antioxid. Redox Signal. 6, 878-887.
77. Mariani, E., Polidori, M. C., Cherubini, A., and Mecocci, P. (2005). Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 827, 65-75
78. Maritim, A. C., Sanders, R. A., and Watkins, J. B. III. (2003). Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24-38.
79. Markesbery, W. R., and Lovell, M. A. (2007). Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 64, 954-956.
80. Marnett, L. J. (1999). Chemistry and biology of DNA damage by malondialdehyde. IARC Sci. Publ. 17-27.
81. McCarty, M. F. (2007). " Iatrogenic Gilbert syndrome" - a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med. Hypotheses 69, 974-994.
82. McDonagh,A. F. (2010). The biliverdinbilirubin antioxidant cycle of cellular protection: missing a wheel? Free Radic Biol. Med. 49, 814-820.
83. Miller, R. L., James-Kracke, M., Sun, G. Y., and Sun, A. Y. (2009). Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 34, 55-65.
84. Mireles, L. C., Lum, M. A., and Dennery, P. A. (1999). Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr. Res. 45, 355-362.
85. Miro, O., Casademont, J., Casals, E., Perea, M., Urbano-Marquez, A., Rustin, P., and Cardellach, F. (2000). Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects. Cardiovasc. Res. 47, 624-631.
86. Mizuno, Y. (1990). The role of oxygen free radicals in the aging of the brain. Nihon Ronen Igakkai Zasshi 27, 182-187.
87. Molavi, B., and Mehta, J. L. (2004). Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol. 19, 488-493.
88. Muralikrishna Adibhatla, R., and Hatcher, J. F. (2006). Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40, 376-387.
89. Nishikawa, Y., Stepp, D. W., Merkus, D., Jones, D., and Chilian, W. M. (2004). In vivo role of heme oxygenase in ischemic coronary vasodilation. Am. J. Physiol. Heart Circ. Physiol. 286, H2296-H2304.
90. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98.
91. Ohrui, T., Higuchi, M., Kanda, A., Matsui,T.,Sato,E.,and Sasaki,H. (2001). A patient with exacerbation of idiopathic pulmonary fibrosis which was resolved probably due to the coexisting hyperbilirubinemia? Tohoku J. Exp. Med. 193, 245-249.
92. Oren, D. A., Desan, P. H., Boutros, N., Anand, A., and Charney, D. S. (2002). Effects of light on low nocturnal bilirubin in winter depression: a preliminary report. Biol. Psychiatry 51, 422-425.
93. Pansarasa, O., Bertorelli, L., Vecchiet, J., Felzani, G., and Marzatico, F. (1999). Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. Free Radic. Biol. Med. 27, 617-622.
94. Park, S. C. (2011). Nuclear barrier hypothesis of aging as mechanism for trade-off growth to survival. Adv. Exp. Med. Biol. 720, 3-13.
95. Plastaras, J. P., Riggins, J. N., Otteneder, M., and Marnett, L. J. (2000). Reactivity and mutagenicity of endogenous DNA oxopropenylating agents: base propenals, malondialdehyde, and N(epsilon)-oxopropenyllysine. Chem. Res. Toxicol. 13, 1235-1242.
96. Poon, H. F., Calabrese, V., Scapagnini, G., and Butterfield, D. A. (2004). Free radicals and brain aging. Clin. Geriatr. Med. 20, 329-359.
97. Pratico, D., Uryu, K., Leight, S., Trojanoswki,J. Q.,and Lee,V. M. (2001). Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183-4187
98. Qin, J., Goswami, R., Balabanov, R., and Dawson, G. (2007). Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J. Neurosci. Res. 85, 977-984.
99. Ravandi,A.,Boekholdt,S. M.,Mallat,Z., Talmud, P. J., Kastelein, J. J., Wareham, N. J., Miller, E. R., Benessiano, J., Tedgui, A., Witztum, J. L., Khaw, K. T., and Tsimikas, S. (2011). Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk study. J. Lipid Res. 52, 1829-1836.
100. Recuero, M., Munoz, T., Aldudo, J., Subias, M., Bullido, M. J., and Valdivieso, F. (2010). A free radicalgenerating system regulates APP metabolism/processing. FEBS Lett. 584, 4611-4618.
101. Riggins, J. N., and Marnett, L. J. (2001). Mutagenicity of the malondialdehyde oligomerization products 2-(3′-oxo-1′- propenyl)-malondialdehyde and 2,4-dihydroxymethylene-3-(2,2-dimethoxyethyl)glutaraldehyde in Salmonella. Mutat. Res. 497, 153-157.
102. Robles, S. J., and Adami, G. R. (1998). Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16, 1113-1123.
103. Rosenthal, P., Pincus, M., and Fink, D. (1984). Sex-and age-related differences in bilirubin concentrations in serum. Clin. Chem. 30, 1380-1382.
104. Salzman, R., Pacal, L., Tomandl, J., Kankova, K., Tothova, E., Gal, B., Kostrica, R., and Salzman, P. (2009). Elevated malondialdehyde correlates with the extent of primary tumor and predicts poor prognosis of oropharyngeal cancer. Anticancer Res. 29, 4227-4231.
105. Schluchter, W. M., and Glazer, A. N. (1997). Characterization of cyanobacterial biliverdin reductase. Conversion of biliverdin to bilirubin is important for normal phycobiliprotein biosynthesis. J. Biol. Chem. 272, 13562-13569.
106. Schmitt, C. A. (2007). Cellular senescence and cancer treatment. Biochim. Biophys. Acta 1775, 5-20.
107. Schwertner, H. A., Jackson, W. G., and Tolan, G. (1994). Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem. 40, 18-23.
108. Sedlak, T. W., Saleh, M., Higginson, D. S., Paul, B. D., Juluri, K. R., and Snyder, S. H. (2009). Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. U.S.A. 106, 5171-5176.
109. Sedlak, T. W., and Snyder, S. H. (2004). Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113, 1776-1782.
110. Seki, T., Curiel, D. T., Naruse, M., and Takano, K. (2000). HO (heme oxygenase)/CO (carbon monoxide) system. Nihon Rinsho 58(Suppl. 1), 188-191.
111. Serrano, M., Lin, A. W., Mccurrach, M. E.,Beach, D.,and Lowe,S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
112. Simpson, E. P., Henry,Y. K., Henkel, J. S., Smith,R. G.,and Appel,S. H. (2004). Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62, 1758-1765.
113. Sohal, R. S., and Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science 273, 59-63.
114. Stein, G. H., Beeson, M., and Gordon, L. (1990). Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 249, 666-669.
115. Stocker, R., and Ames, B. N. (1987). Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc. Natl. Acad. Sci. U.S.A. 84, 8130-8134.
116. Stocker, R., Mcdonagh, A. F., Glazer, A. N., and Ames, B. N. (1990). Antioxidant activities of bile pigments: biliverdin and bilirubin. Meth. Enzymol. 186, 301-309.
117. Stoyanovsky, D., Murphy, T., Anno, P. R., Kim, Y. M., and Salama, G. (1997). Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21, 19-29.
118. Takahashi, M., Dore, S., Ferris, C. D., Tomita, T., Sawa, A., Wolosker, H., Borchelt, D. R., Iwatsubo, T., Kim, S. H.,Thinakaran,G.,Sisodia,S. S.,and Snyder, S. H. (2000). Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28, 461-473.
119. Tudor, C., Lerner-Marmarosh, N., Engelborghs, Y., Gibbs, P. E., and Maines, M. D. (2008). Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. Biochem. J. 413, 405-416.
120. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84.
121. Van Hoydonck, P. G., Temme, E. H., and Schouten, E. G. (2001). Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int. J. Epidemiol. 30, 1465-1472.
122. Vitek, L., Jirsa, M., Brodanova, M., Kalab, M., Marecek, Z., Danzig, V., Novotny, L., and Kotal, P. (2002). Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160, 449-456.
123. Ward, W. F., Qi, W., Van Remmen, H., Zackert, W. E., Roberts, L. J., 2nd and Richardson, A. (2005). Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels. J. Gerontol. A Biol. Sci. Med. Sci. 60, 847-851.
124. Wegiel, B., Baty, C. J., Gallo, D., Csizmadia, E., Scott, J. R., Akhavan, A., Chin, B. Y., Kaczmarek, E., Alam, J., Bach, F. H., Zuckerbraun, B. S., and Otterbein, L. E. (2009). Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 284, 21369-21378.
125. Wu, B., Liu, X., and Shen, J. (2008). Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target. Med. Hypotheses 71, 73-76.
126. Wu, T. W., Fung, K. P., Wu, J., Yang, C. C., and Weisel, R. D. (1996). Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem. Pharmacol. 51, 859-862.
127. Yuan, X. M., and Li, W. (2003). The iron hypothesis of atherosclerosis and its clinical impact. Ann. Med. 35, 578-591.
128. Zanetti, M., Gortan Cappellari, G., Burekovic, I., Barazzoni, R., Stebel, M., and Guarnieri, G. (2010). Caloric restriction improves endothelial dysfunction during vascular aging: effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. Exp. Gerontol. 45, 848-855.
129. Zhang, L., Liu, W., Tanswell, A. K., and Luo, X. (2003). The effects of bilirubin on evoked potentials and long-term potentiation in rat hippocampus in vivo. Pediatr. Res. 53, 939-944.
130. Zhu, J., Woods, D., Mcmahon, M., and Bishop, J. M. (1998). Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007.
131. Zhu, X., Lee, H. G., Perry, G., and Smith, M. A. (2007). Alzheimer disease, the two-hit hypothesis: an update. Biochim. Biophys. Acta 1772, 494-502.
132. Zucker, S. D., Benedict, M., and Sherman, K. E. (2006). Serum bilirubin and risk of colorectal cancer. Aliment. Pharmacol. Ther. 24, 1257-1259.